Simcere Pharmaceutical Group (NYSE:SCR)
CAPS Rating:
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.
Growing the love for investing
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
China is paying the price for their rapid industrial growth in high rates of Cancer and Lung Disease related to the air pollution. China is trying to shift to a green energy model, but in the meantime they have a lot of sick people needing cheap medicines, which this company manufactures. Stock is currently near 52 week low, with loads of upward growth potential in their market. Good long term buy in my opinion.